Related Articles
Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection
Cholesteryl 14-methylhexadecanoate as a possible marker of malignant tumours
Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer
Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
PROSPECTIVE MULTICENTER STUDY ON THE CLINICAL UTILITY OF CA-72.4 IN POSTMENOPAUSAL PATIENTS WITH PELVIC MASS